| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $691.0M | -2.9% |
| Cost of Revenue | $478.0M | -2.1% |
| Gross Profit | $213.0M | -4.6% |
| R&D Expense | $10.9M | +17.1% |
| SG&A Expense | $173.3M | +5.5% |
| Operating Income | $39.7M | -32.9% |
| Interest Expense | $1.1M | -83.0% |
| Pre-tax Income | $39.7M | -11.6% |
| Income Tax | $5.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.9M | -3.3% |
| Accounts Receivable | $131.6M | +6.3% |
| Inventory | $52.8M | +0.3% |
| Current Assets | $268.7M | +5.2% |
| Total Assets | $444.9M | +11.5% |
| Current Liabilities | $149.4M | +0.1% |
| Total Liabilities | $204.0M | +0.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $38.9M | -41.3% |
| Capital Expenditures | $11.2M | +26.3% |
| Investing Cash Flow | -$12.9M | -44.7% |
| Financing Cash Flow | -$26.9M | +62.8% |
| Free Cash Flow | $27.7M | -51.8% |
| -19.0% |
| Net Income | $33.9M | -11.7% |
| EPS (Basic) | $3.27 | -11.6% |
| EPS (Diluted) | $3.14 | -9.8% |
| Stockholders' Equity |
| $240.3M |
| +26.9% |